Literature DB >> 11766888

Human papillomaviruses and their role in cervical cancer.

G Dell1, K Gaston.   

Abstract

Human papillomaviruses (HPVs) have been linked to a variety of human diseases, most notably cancer of the cervix, a disease responsible for at least 200,000 deaths per year worldwide. Over 100 different types of HPV have been identified and these can be divided into two groups. Low-risk HPV types are the causative agent of benign warts. High-risk HPV types are associated with cancer. This review focuses on the role of high-risk HPV types in cervical tumorigenesis. Recent work has uncovered new cellular partners for many of the HPV early proteins and thrown light on many of the pathways and processes in which these viral proteins intervene. At the same time, structural and biochemical studies are revealing the molecular details of viral protein function. Several of these new avenues of research have the potential to lead to new approaches to the treatment and prevention of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766888     DOI: 10.1007/pl00000827

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  32 in total

1.  Integration of human papillomavirus 18 DNA in esophageal carcinoma 109 cells.

Authors:  Ke Zhang; Jin-Tao Li; Shu-Ying Li; Li-Hua Zhu; Ling Zhou; Yi Zeng
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold.

Authors:  Alejandro D Nadra; Tommaso Eliseo; Yu-Keung Mok; C L Almeida; Mark Bycroft; Maurizio Paci; Gonzalo de Prat-Gay; Daniel O Cicero
Journal:  J Biomol NMR       Date:  2004-10       Impact factor: 2.835

3.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

5.  Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins.

Authors:  Marta Melar-New; Laimonis A Laimins
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Authors:  Yves Nominé; Sebastian Charbonnier; Laurent Miguet; Noelle Potier; Alain Van Dorsselaer; R Andrew Atkinson; Gilles Travé; Bruno Kieffer
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

7.  Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

Authors:  Grant A Darnell; Toni M Antalis; Barbara R Rose; Andreas Suhrbier
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets.

Authors:  Yingfei Ma; Ramana Madupu; Ulas Karaoz; Carlos W Nossa; Liying Yang; Shibu Yooseph; Patrick S Yachimski; Eoin L Brodie; Karen E Nelson; Zhiheng Pei
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

10.  Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.

Authors:  Shirin Kazemi; Stavroula Papadopoulou; Suiyang Li; Qiaozhu Su; Shuo Wang; Akihiko Yoshimura; Greg Matlashewski; Thomas E Dever; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.